Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Aclidinium Bromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AZN completes transfer of global rights to Eklira & Duaklir to Covis Pharma
    AZN completes transfer of global rights to Eklira & Duaklir to Covis Pharma

    06 Jan 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145059&sid=2

    PHARMABIZ
    06 Jan 2022
    Share Share
    AstraZeneca sells 2 COPD inhalers to familiar face
    AstraZeneca sells 2 COPD inhalers to familiar face

    02 Nov 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/pharma/astrazeneca-resumes-asset-sale-270m-copd-deal-familiar-buyer-covis

    Angus Liu FIERCEPHARMA
    02 Nov 2021
    Share Share
    A three-decade monopoly: How Amgen built a patent thicket top-selling drug
    A three-decade monopoly: How Amgen built a patent thicket top-selling drug

    30 Oct 2021

    // Jonathan Gardner BIOPHARMADIVE

    https://www.biopharmadive.com/news/amgen-enbrel-patent-thicket-monopoly-biosimilar/609042/

    Jonathan Gardner BIOPHARMADIVE
    30 Oct 2021
    Share Share
    Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® for patients with COPD
    Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® for patients with COPD

    21 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/circassia-pharmaceuticals-launches-duaklir-pressair-aclidinium-formoterol-for-patients-with-chronic-obstructive-pulmonary-disease-copd-/?s=95

    BIOSPACE
    21 Oct 2019
    Share Share
    US Food and Drug Administration Approves DUAKLIR® PRESSAIR®
    US Food and Drug Administration Approves DUAKLIR® PRESSAIR®

    17 Apr 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190417005363/en/Food-Drug-Administration-Approves-DUAKLIR%C2%AE-PRESSAIR%C2%AE-aclidiniumformoterol/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    BUSINESSWIRE
    17 Apr 2019
    Share Share
    FDA Approves TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) sNDA)
    FDA Approves TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) sNDA)

    01 Apr 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190329005556/en/FDA-Approves-TUDORZA%C2%AE-PRESSAIR%C2%AE-aclidinium-bromide-inhalation/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    01 Apr 2019
    Share Share